Personalized versus non-personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysis.
Colombet
Isabelle
I
Public Health and Medical Informatics, Georges Pompidou European Hospital, Paris, France. isabelle.colombet@spim.jussieu.fr
Bura-Rivière
Alessandra
A
Chatila
Rémy
R
Chatellier
Gilles
G
Durieux
Pierre
P
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000453:epidemiology; D018890:Chemoprevention / Q000009:adverse effects / Q000592:standards; D016303:Clinical Pharmacy Information Systems; D020000:Decision Support Systems, Clinical; D017723:Drug Utilization Review; D005602:France; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D008505:Medical Staff, Hospital / Q000193:education / Q000523:psychology; D008508:Medication Errors / Q000009:adverse effects / Q000517:prevention & control*; D049451:Nomograms; D010630:Phenindione / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011786:Quality Control; D017010:Reminder Systems; D018511:Systems Integration; D013995:Time; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D010630:Phenindione; D014859:Warfarin; C017673:fluindione